165 related articles for article (PubMed ID: 30530405)
21. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
[TBL] [Abstract][Full Text] [Related]
22. Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia/lymphoma.
Hashikawa K; Yasumoto S; Nakashima K; Arakawa F; Kiyasu J; Kimura Y; Saruta H; Nakama T; Yasuda K; Tashiro K; Kuhara S; Hashimoto T; Ohshima K
Int J Oncol; 2014 Sep; 45(3):1200-8. PubMed ID: 24970722
[TBL] [Abstract][Full Text] [Related]
23. Tissue and serum lipidome shows altered lipid composition with diagnostic potential in mycosis fungoides.
Xu C; Zhou D; Luo Y; Guo S; Wang T; Liu J; Liu Y; Li Z
Oncotarget; 2017 Jul; 8(29):48041-48050. PubMed ID: 28624795
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.
Möbs M; Gryzik S; Haidar A; Humme D; Beyer M; Vandersee S
Arch Dermatol Res; 2015 Aug; 307(6):479-85. PubMed ID: 25488078
[TBL] [Abstract][Full Text] [Related]
25. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).
Cirée A; Michel L; Camilleri-Bröet S; Jean Louis F; Oster M; Flageul B; Senet P; Fossiez F; Fridman WH; Bachelez H; Tartour E
Int J Cancer; 2004 Oct; 112(1):113-20. PubMed ID: 15305382
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis.
Gu X; Wang Y; Zhang G; Li W; Tu P
J Dermatol; 2013 Aug; 40(8):596-605. PubMed ID: 23682716
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor (TLR)7 expression in mycosis fungoides and psoriasis: a case-control study.
El Tawdy AM; Amin IM; Abdel Hay RM; Hassan AS; Gad ZS; Rashed LA
Clin Exp Dermatol; 2017 Mar; 42(2):172-177. PubMed ID: 28054376
[TBL] [Abstract][Full Text] [Related]
28. Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study.
Elmasry MF; Obaid YA; El-Samanoudy SI; Nour ZA; Doss SS
Arch Dermatol Res; 2024 Jun; 316(7):349. PubMed ID: 38850434
[TBL] [Abstract][Full Text] [Related]
29. Mycosis Fungoides and Vitamin D Status: Analyses of Serum 25-Hydroxyvitamin D Levels and Single Nucleotide Polymorphisms in the Vitamin D Receptor Gene.
Incel Uysal P; Alli N; Hayran Y; Candar T
Acta Dermatovenerol Croat; 2018 Apr; 26(1):8-14. PubMed ID: 29782293
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors for Skin Infections in Mycosis Fungoides.
Lebas E; Arrese JE; Nikkels AF
Dermatology; 2016; 232(6):731-737. PubMed ID: 28249285
[TBL] [Abstract][Full Text] [Related]
31. Hypopigmented mycosis fungoides: case reports and literature review.
Qari MS; Li N; Demierre MF
J Cutan Med Surg; 2000 Jul; 4(3):142-8. PubMed ID: 11003719
[TBL] [Abstract][Full Text] [Related]
32. Altered microRNA expression in mycosis fungoides.
Maj J; Jankowska-Konsur A; Sadakierska-Chudy A; Noga L; Reich A
Br J Dermatol; 2012 Feb; 166(2):331-6. PubMed ID: 21966986
[TBL] [Abstract][Full Text] [Related]
33. Progranulin and beta-catenin in psoriasis: An immunohistochemical study.
Farag AGA; Shoaib MA; Samaka RM; Abdou AG; Mandour MM; Ibrahim RAL
J Cosmet Dermatol; 2019 Dec; 18(6):2019-2026. PubMed ID: 31091001
[TBL] [Abstract][Full Text] [Related]
34. Reduction of PGRN increased fibrosis during skin wound healing in mice.
Li SS; Zhang MX; Wang Y; Wang W; Zhao CM; Sun XM; Dong GK; Li ZR; Yin WJ; Zhu B; Cai HX
Histol Histopathol; 2019 Jul; 34(7):765-774. PubMed ID: 30561754
[TBL] [Abstract][Full Text] [Related]
35. Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides.
Mascolo M; Romano MF; Ilardi G; Romano S; Baldo A; Scalvenzi M; Argenziano G; Merolla F; Russo D; Varricchio S; Pagliuca F; Russo M; Ciancia G; De Rosa G; Staibano S
J Eur Acad Dermatol Venereol; 2018 May; 32(5):735-744. PubMed ID: 28977697
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-33 polymorphisms and serum concentrations in mycosis fungoides.
Rustowska-Rogowska A; Gleń J; Jarząbek T; Rogowski W; Rębała K; Zabłotna M; Czajkowska K; Nowicki R; Kowalczyk A; Sokołowska-Wojdyło M
Int J Dermatol; 2020 Mar; 59(3):345-351. PubMed ID: 31663123
[TBL] [Abstract][Full Text] [Related]
37. Protein and mRNA Expression Levels of Interleukin-17A, -17F and -22 in Blood and Skin Samples of Patients with Mycosis Fungoides.
Papathemeli D; Patsatsi A; Papanastassiou D; Koletsa T; Papathemelis T; Avgeros C; Pikou O; Lazaridou E; Georgiou E
Acta Derm Venereol; 2020 Nov; 100(18):adv00326. PubMed ID: 33170303
[TBL] [Abstract][Full Text] [Related]
38. Reduced expression of CDKN2a/P16INK4a in mycosis fungoides.
Peris K; Stanta G; Fargnoli MC; Bonin S; Felli A; Amantea A; Chimenti S
Arch Dermatol Res; 1999 Apr; 291(4):207-11. PubMed ID: 10335917
[TBL] [Abstract][Full Text] [Related]
39. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
[TBL] [Abstract][Full Text] [Related]
40. Mycosis fungoides: association of KIR ligands and HLA-DQB1*05 with bad prognosis of the disease.
Brazzelli V; Rivetti N; Badulli C; Carugno A; Cananzi R; De Silvestri A; Martinetti M; Borroni G
J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):266-9. PubMed ID: 25753140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
